# Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

> **NCT03316404** · — · COMPLETED · sponsor: **DxTerity Diagnostics** · enrollment: 1168 (actual)

## Conditions studied

- Multiple Sclerosis
- MS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03316404
- **Lead sponsor:** DxTerity Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-07
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-02-25
- **Target enrollment:** 1168 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03316404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03316404, "Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03316404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*